ArticleAnnals of translational medicine2020

Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?

Monica Balzarotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.